Category: Health Care Costs

Here we go again: Another day, another six-figure drug price

Instead of acknowledging the growing consumer concern and outrage over soaring prices for medical services, media reports today show drugmakers are still turning a blind eye, slapping more six-figure price tags on critical treatments. Continue reading

Posted in: Health Care Costs

The Price Is High and Stays There

The price of tests and scans continue to increase, although the equipment used to perform the procedures has become less expensive. Continue reading

Posted in: Health Care Costs

FTC Chairwoman: Why Provider Consolidation is So Worrisome

Health care providers, policymakers, and patients should be worried about the provider consolidation trend because more consolidation means less competition, Federal Trade Commission Chairwoman Edith Ramirez wrote in the New England Journal of Medicine. Continue reading

Posted in: Health Care Costs

TEDMED: Tackling the Challenges of Accessibility and Affordability in Health Care

AHIP’s VP for Policy Greg Gierer today joined a group of experts to discuss health care pricing and sustainability. They tackled the question of how to make innovative treatments more accessible to patients while reining in the high cost of care. Continue reading

Posted in: Health Care Costs

Chart of the day: Spending on specialty drugs takes off

Specialty drugs account for a small fraction of prescribed medications among Medicaid beneficiaries, but they continue to dominate spending. Continue reading

Posted in: Health Care Costs

Exorbitant drug prices put quality of life and quality of care at risk

The increasing cost of drugs is creating a “financially toxic” cycle that harms the quality of life and quality of care of cancer patients and survivors, according to experts who spoke at the American Society of Hematology’s annual meeting in San Francisco. Continue reading

Posted in: Health Care Costs

Fact: The real problem is abusive drug pricing

Biosimilars can save millions of dollars and save many lives. That was the message shared by all of the panelists at a discussion this morning hosted by The Hill in Washington, D.C. Continue reading

Posted in: Fact Check, Health Care Costs

Heed the Price Warnings on Provider Consolidation

The growing trend of provider consolidation is expected to continue, which means so too will major medical price increases. With merger mania building up speed, health care leaders, policymakers, and consumers should heed warnings about the dangerous, long-term effects of anticompetitive provider consolidation. Continue reading

Posted in: Health Care Costs

Deep Dive: The Backstory on Sovaldi’s Sky-High Price Tag

A new Vox article gives the story behind Gilead’s $84,000 hepatitis C drug Sovaldi. And the moral of the story is that the sky’s the limit for drug prices in the United States. Continue reading

Posted in: Health Care Costs

Provider consolidation: A lot of evidence and a lot at stake

Provider consolidation sets off a chain reaction that leads to higher prices for consumers, The Journal News reports. Continue reading

Posted in: Health Care Costs